Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical R&D.

Central to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros' senior leadership. While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

Syros Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Life Science, Pharmaceutical, Genetics sector. The company focuses on Biotechnology and has secured $109.2B in funding across 176 round(s). With a team of 101-250 employees, Syros Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Syros Pharmaceuticals, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.